Unlock instant, AI-driven research and patent intelligence for your innovation.

Formulation comprising thymol useful in treatment of drug resistant bacterial infections

A bacterial infection, thymol technology, applied in antibacterial drugs, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve problems such as single multidrug tolerance of infection

Inactive Publication Date: 2007-09-26
COUNCIL OF SCI & IND RES
View PDF19 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The indiscriminate and overuse of commonly available antibiotics has consistently led to the emergence of single and multidrug resistance in infections

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] The antibacterial activity of Trychyspermum ammi oil, thymol, and the thymol-free fraction of the oil was determined using a disk diffusion assay, expressed as the zone of growth inhibition produced on the lawn of resistant strains (Table 1).

[0058] large intestine rod

[0059] Here, CA8000 is a wild-type strain of E. coli, DH5α and ET8000 have a cryptic gyr mutation, that is, the gene encoding the Gyr A subunit of DNA gyrase responsible for DNA relaxation is modified. Since the DNA gyrase is altered, these mutants are resistant to quinolones. Specific mutations were confirmed by gene complementation by transfer of the plasmid that cloned gyr A. As shown in the table, the killing zone of thymol was greater in the case of gyr mutant strains tolerant to the above drugs. No activity was observed in the thymol-free fraction of the oil.

Embodiment 2

[0061] Sensitivity of nalidixic acid-tolerant Escherichia coli strains to different antibiotics determined by toxic agar

[0062] Independent mutants tolerant to nalidixic acid were isolated in E. coli by introduced and spontaneous gene mutations in the wild-type CA8000 strain. They were then tested for patterns of sensitivity to nalidixic acid and other next-generation quinolones and fluoroquinolones, since resistance to second- and third-generation drugs is also caused only by mutations in the gyrA gene.

[0063] Table 2 below shows the cross-resistance patterns of these mutants.

[0064] Escherichia coli

mutant

(Nal R ) strain

Growth on toxic agar medium containing

nalidixic acid

Oxolinic acid

Sifloxacin

Ciprofloxacin

Lomefloxacin

50μg / ml

5μg / ml

5μg / ml

5μg / ml

5μg / ml

CAN 101

+

-

+

-

-

CAN 102

+

-

+

-

-

CAN...

Embodiment 3

[0068] Thymol against E. coli Nal R Biological evaluation of mutant activity

[0069] Test the sensitivity of the above-mentioned mutants to thymol, and further confirm the above-mentioned hypothesis, that is, Nal of Escherichia coli R The mutants were instead effectively killed by thymol, thus illustrating its use as a plant antibiotic to control resistant bacteria. Thymol was clearly shown in these assays against all Nal R Activity of the mutants, whether single or multidrug resistant (Table 3).

[0070] Mutations in E. coli

Body (Nal R ) strain

Thymol (mm of zone of inhibition)

50μg / plate

100μg / plate

250μg / plate

CAN 101

Tr.

1.5

4.0

CAN 102

Tr.

2.0

7.0

CAN 103

Tr.

2.0

4.0

CAN 104

Tr.

2.0

6.0

CAN 105

Tr.

2.0

5.0

CAN 106

1

2.0

4.0

CAN 107

1

3.0

5.0

CAN 108

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Novel formulation useful in the treatment of drug resistant bacterial infections comprising an effective amount of "Thymol" obtained from the plant Trychyspermum ammi, combination of mint oil containing appropriate amounts of monoterpene obtained from Mentha spicata and Mentha arvensis and obtaining conventional additives, a method for producing the formulation by mixing the above ingredients and a method for the treatment of drug resistant in a patient by administration of a therapeutically effective amount of the said formulation.

Description

field of invention [0001] The present invention relates to novel synergistic compositions useful in the treatment of drug-resistant bacterial infections, said compositions comprising effective amounts of thymol, a mixture of essential oils of field mint (Mentha arvensis) and spearmint (Mentha spicata) in appropriate proportions or Its monoterpene component and conventional additives. The composition can be used to treat drug-resistant intestinal and systemic infections. A preparation that potentiates the activity of thymol comprises thymol in combination with said essential oil, a combination containing a rare mixture of carvone, 1,8-terpene and menthol. The present invention also provides a method of producing said composition and a method of using thymol obtained from the seeds of the plant Trychyspermum ammi (Ajwain) as a fourth generation antibiotic preparation for the control of resistant bacteria. More precisely, the present invention relates to the use of the compound...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/05A61K31/12A61K36/53A61P31/04
Inventor 叙曼·普里特·辛格·哈努佳苏基·斯里瓦斯塔瓦阿吉特·库马尔·沙森马亨德拉·潘杜拉恩·达罗克蒂鲁帕迪瑞普里尤尔·桑塔·库马尔克里希纳·库马尔·阿加瓦尔阿提克·艾哈迈德尼马尔·库马尔·帕特拉普拉什·辛哈苏尼蒂·达万达芒德尔·赛基亚苏希尔·库马尔
Owner COUNCIL OF SCI & IND RES